Trase
Summary active Updated Jun 25, 2026This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.
Investors
Founders
About
Trase is an AI operating system company building agentic infrastructure for highly regulated industries such as healthcare and defense 1. The company was incubated by Red Cell Partners and publicly launched in late 2025 2. Its core platform, Trase Origin, deploys specialized agents inside customer environments — for example, Duke University Health System’s Division of Cardiology, where Trase agents automate the more than 5,000 faxes the clinic receives each month, work previously handled by hand by medical assistants and nurses 2. The company has offices in Seattle and the Washington, D.C. metro area, with a team of 55 2.
Funding History
| Date | Round | Amount | Lead | Co-investors |
|---|---|---|---|---|
| 2026-06-25 | Seed | $107M | ARCH Venture Partners | Red Cell Partners 12 |
This round brought Trase’s total funding to $117.5M 2.
What Investors Say
No independently sourced investor quotes found at this time.
What Founders Say
No independently sourced founder testimonials found at this time.
Sources
-
BusinessWire, “Trase Raises $107M Seed Round Led by ARCH Venture Partners to Continue Building Agentic Operating System for Regulated Industries,” June 25, 2026. https://www.businesswire.com/news/home/20260625167565/en/Trase-Raises-$107M-Seed-Round-Led-by-ARCH-Venture-Partners-to-Continue-Building-Agentic-Operating-System-for-Regulated-Industries↩↩
-
Pulse 2.0, “Trase Raises $107 Million Seed Round Led By ARCH Venture Partners,” June 25, 2026. https://pulse2.com/trase-raises-107-million-seed-round-led-by-arch-venture-partners/↩↩↩↩↩